AITEM

Live / Registered — Registered (as of 30 Apr 2024)

What this means for you

Registered since 30 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79350047
Registration number
7369448
Mark type
Stylized text
Filed
15 Jul 2022
Published for opposition
13 Feb 2024
Registered
30 Apr 2024
Attorney of record
MARK E. BANDY

Goods and services

  • Class 005 — Pharmaceuticals: Medicines for human purposes, namely, for use for central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Chemico-pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Capsules being medicines, namely, capsules for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney related diseases, gastrointestinal diseases; Sedatives; Vaccines; Drugs for medical purposes, namely, central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Medicines in tablet form, namely, medicinal preparations for the mouth to be applied in the form of tablets; Injectable medicinal solutions, namely, powder for injection, parenteral solutions, solutions for injection, intravenous injections, suspensions for injection, sterile powders for injection, intravenous injections, emulsion for injection, emulsion injections, powder injections, and concentrated solutions for injection, all for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pain relief medication; Immunostimulants; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of viral diseases; Medicinal preparations for the treatment of musculoskeletal disorders; Drugs and preparations for the treatment of gastrointestinal diseases; Medicinal preparations for skin diseases
  • Class 042 — Scientific and technological services: Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Pharmaceutical research; Scientific research and development; Conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Computer hardware design; Research and development of new products for others; Providing computer software design for others; Electronic data storage; Conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; Conversion of data or documents from physical to electronic media; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; Computer programming

Owner

Prosecution history

  • 07 Dec 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 27 Oct 2024 — GENERIC MADRID TRANSACTION SENT TO IB
  • 26 Oct 2024 — GENERIC MADRID TRANSACTION CREATED
  • 30 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 30 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 30 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 30 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
  • 17 Mar 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
  • 26 Feb 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 21 Feb 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
  • 19 Feb 2024 — NOTIFICATION PROCESSED BY IB
  • 13 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 13 Feb 2024 — PUBLISHED FOR OPPOSITION
  • 29 Jan 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 24 Jan 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

View this trademark record on Marksy